Benedict Financial Advisors Inc Bristol Myers Squibb CO Transaction History

Benedict Financial Advisors Inc

  • $435 Million
  • Q2 2025

A detailed history of Benedict Financial Advisors Inc transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Benedict Financial Advisors Inc holds 66,577 shares of BMY stock, worth $3.03 Million. This represents 0.71% of its overall portfolio holdings.

Number of Shares
66,577
Previous 66,567 0.02%
Holding current value
$3.03 Million
Previous $4.06 Million 24.09%
% of portfolio
0.71%
Previous 0.95%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 13, 2025
BUY
$44.12 - $59.6 $441 - $596
10 Added 0.02%
66,577 $3.08 Million
Q1 2025

May 07, 2025
BUY
$53.9 - $63.11 $23,931 - $28,020
444 Added 0.67%
66,567 $4.06 Million
Q4 2024

Jan 28, 2025
BUY
$51.92 - $59.94 $42,418 - $48,970
817 Added 1.25%
66,123 $3.74 Million
Q3 2024

Oct 24, 2024
SELL
$39.66 - $51.75 $262,945 - $343,102
-6,630 Reduced 9.22%
65,306 $3.38 Million
Q2 2024

Jul 30, 2024
SELL
$40.25 - $52.99 $134,636 - $177,251
-3,345 Reduced 4.44%
71,936 $2.99 Million
Q1 2024

Apr 25, 2024
BUY
$47.98 - $54.4 $71,202 - $80,729
1,484 Added 2.01%
75,281 $4.08 Million
Q4 2023

Jan 29, 2024
SELL
$48.48 - $57.85 $6,884 - $8,214
-142 Reduced 0.19%
73,797 $3.79 Million
Q3 2023

Oct 18, 2023
BUY
$57.89 - $64.73 $77,804 - $86,997
1,344 Added 1.85%
73,939 $4.29 Million
Q2 2023

Aug 10, 2023
BUY
$63.71 - $70.74 $93,080 - $103,351
1,461 Added 2.05%
72,595 $4.64 Million
Q1 2023

May 11, 2023
BUY
$65.71 - $74.53 $129,251 - $146,600
1,967 Added 2.84%
71,134 $4.93 Million
Q4 2022

Feb 14, 2023
BUY
$68.48 - $81.09 $75,944 - $89,928
1,109 Added 1.63%
69,167 $4.98 Million
Q3 2022

Nov 07, 2022
BUY
$0.13 - $76.84 $74 - $43,798
570 Added 0.84%
68,058 $4.84 Million
Q2 2022

Jul 28, 2022
BUY
$72.62 - $79.98 $129,917 - $143,084
1,789 Added 2.72%
67,488 $5.2 Million
Q1 2022

May 03, 2022
BUY
$61.48 - $73.72 $155,421 - $186,364
2,528 Added 4.0%
65,699 $4.8 Million
Q4 2021

Feb 09, 2022
BUY
$53.63 - $62.52 $172,205 - $200,751
3,211 Added 5.36%
63,171 $3.94 Million
Q3 2021

Oct 29, 2021
BUY
$59.17 - $69.31 $118,458 - $138,758
2,002 Added 3.45%
59,960 $3.55 Million
Q2 2021

Aug 05, 2021
BUY
$61.91 - $67.42 $155,332 - $169,156
2,509 Added 4.52%
57,958 $3.87 Million
Q1 2021

May 10, 2021
BUY
$59.34 - $66.74 $172,323 - $193,812
2,904 Added 5.53%
55,449 $3.5 Million
Q4 2020

Feb 02, 2021
BUY
$57.74 - $65.43 $245,510 - $278,208
4,252 Added 8.8%
52,545 $3.26 Million
Q3 2020

Nov 03, 2020
BUY
$57.43 - $63.64 $242,871 - $269,133
4,229 Added 9.6%
48,293 $2.91 Million
Q2 2020

Jul 23, 2020
BUY
$54.82 - $64.09 $27,958 - $32,685
510 Added 1.17%
44,064 $2.59 Million
Q1 2020

Apr 21, 2020
BUY
$46.4 - $67.43 $39,161 - $56,910
844 Added 1.98%
43,554 $2.43 Million
Q4 2019

Feb 04, 2020
BUY
$49.21 - $64.19 $140,396 - $183,134
2,853 Added 7.16%
42,710 $2.74 Million
Q3 2019

Nov 04, 2019
BUY
$42.77 - $50.71 $131,817 - $156,288
3,082 Added 8.38%
39,857 $2.02 Million
Q2 2019

Aug 01, 2019
BUY
$44.62 - $49.34 $341,343 - $377,451
7,650 Added 26.27%
36,775 $1.67 Million
Q1 2019

May 01, 2019
BUY
$45.12 - $53.8 $110,183 - $131,379
2,442 Added 9.15%
29,125 $1.39 Million
Q4 2018

Jan 30, 2019
BUY
$48.76 - $63.23 $69,970 - $90,735
1,435 Added 5.68%
26,683 $1.39 Million
Q3 2018

Nov 05, 2018
BUY
$55.19 - $62.25 $53,755 - $60,631
974 Added 4.01%
25,248 $1.57 Million
Q2 2018

Jul 24, 2018
BUY
$50.53 - $62.98 $190,548 - $237,497
3,771 Added 18.39%
24,274 $1.34 Million
Q1 2018

May 02, 2018
BUY
$59.92 - $68.98 $224,819 - $258,812
3,752 Added 22.4%
20,503 $1.3 Million
Q4 2017

Feb 05, 2018
BUY
$59.94 - $65.35 $609,350 - $664,348
10,166 Added 154.38%
16,751 $1.03 Million
Q3 2017

Oct 26, 2017
BUY
$55.23 - $63.74 $363,689 - $419,727
6,585
6,585 $420,000

Others Institutions Holding BMY

# of Institutions
2,676
Shares Held
1.64B
Call Options Held
22.4M
Put Options Held
25.4M
View Full List

About BRISTOL MYERS SQUIBB CO

BMY Quotes by TradingView
  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $96.6B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Benedict Financial Advisors Inc Portfolio

Follow Benedict Financial Advisors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Benedict Financial Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Benedict Financial Advisors Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email